Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/10925
Title: Neuropeptide S produces antinociceptive effects at the supraspinal level in mice
Authors: Li, W
Chang, M
Peng, YL
Gao, YH
Zhang, JN
Han, RW
Wang, R
Keywords: [D-Cys(tBu)5]NPS
Antinociception
Hot-plate test
Neuropeptide S (NPS)
NPS receptor (NPSR)
Tail withdrawal test
Issue Date: 2009
Publisher: Elsevier Science Bv
Source: Regulatory peptides, 2009, v. 156, no. 1-3, p. 90-95 How to cite?
Journal: Regulatory Peptides 
Abstract: Neuropeptide S (NPS), a recently identified bioactive peptide through reverse pharmacology approach, was reported to regulate arousal, anxiety, locomotor activity, feeding behaviors and drug reward. NPS receptor (NPSR) mRNA was found in the area related to the descending control system of pain, such as the periaqueductal gray (PAG), raphe nuclei, and lateral parabrachial nucleus (PBN), suggesting a possible role of the NPS-NPSR system in the regulation of pain transmission. In the present study, we evaluated the effects of NPS in pain modulation at the supraspinal level for the first time, using the tail withdrawal test and hot-plate test in mice. NPS (mouse, 0.01-1 nmol) injected intracerebroventricularly (i.c.v.) caused a significant increase of tail withdrawal latency and paw-licking/jumping latency in the tail withdrawal test and the hot-plate test, respectively. Antinociceptive effect elicited by NPS (0.1 nmol, i.c.v.) was not affected by naloxone (i.c.v., 10 nmol co-injection or i.p., 10 mg/kg, 10 min prior to NPS) in both tail withdrawal test and hot-plate test. However, at the doses, naloxone significantly inhibited the antinociceptive effect induced by morphine (i.c.v., 3 nmol). NPS (0.1 nmol, i.c.v.)-induced antinociception was inhibited by co-injection with 10 nmol, but not 3 nmol [D-Cys(tBu)5]NPS, a peptidergic antagonist identified more recently, while [D-Cys(tBu)5]NPS (3 and 10 nmol) alone induced neither hyperalgesia nor antinociception. These results revealed that NPS could produce antinociception through NPS receptor, but not opioid receptor, and NPS-NPSR system could be a potential target for developing new analgesic drugs.
URI: http://hdl.handle.net/10397/10925
DOI: 10.1016/j.regpep.2009.03.013
Appears in Collections:Journal/Magazine Article

Access
View full-text via PolyU eLinks SFX Query
Show full item record

SCOPUSTM   
Citations

32
Last Week
0
Last month
0
Citations as of May 22, 2017

WEB OF SCIENCETM
Citations

30
Last Week
0
Last month
0
Citations as of May 21, 2017

Page view(s)

28
Last Week
3
Last month
Checked on May 21, 2017

Google ScholarTM

Check

Altmetric



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.